The aim of this study was to investigate changes in expression levels of immune factors of peripheral blood mononuclear cells (PBMC) after oral supplementation of live yeast Saccharomyces cerevisiae to healthy Japanese Black (JB) calves. This study examined JB calves (N = 28): 14 calves (SC Group) received 10 g/calf/day of Saccharomyces cerevisiae (SC) (Acti-Saf Sc 47), and the other calves did not receive supplement (Control Group). Blood samples were collected 9 times during experimental period (1, 2, 3, 4, 5, 6, 7, 8 and 9 months of age), and analyzed for cytokines and chemokines mRNA expression of PBMC using Real-time PCR. The level of beta Hydroxybutanoic acid (BHB) in the SC Group was significantly high at 7 and 8 months of age compared to that in the Control Group. Lymphocyte counts in the SC Group were significantly higher at 2 and 5 to 6 months of age compared to the Control Group. Significant differences were found for IL-12p40 level at 4, 7 and 9 months of age, and for IFN-γ level at 6, 7 and 8 months of age. The level of CXCR3 was significantly higher at 6 to 7 months of age by dietary SC supplementation. These results indicated that SC supplementation improved the cellular immune responses of JB calves.

Introduction Early vaccination of cattle with an inactivated commercial bacterial vaccine against bovine respiratory disease has been reported to increase antibody production and can alleviate the disease. However, its dosage has been little investigated in young Holstein calves. This study addresses the need to establish guide values for vaccine dosage in these animals. Material and Methods Healthy calves received an inactivated vaccine for Histophilus somni, Pasteurella multocida and Mannheimia haemolytica intramuscularly at the ages of 1 and 4 weeks. Administered vaccine doses were 1.0 mL for the primary and booster vaccinations (1.0 + 1.0 group), 0.5 mL for the primary and 1.0 mL for the booster vaccination (0.5 + 1.0 group), or 0.5 mL for both vaccinations (0.5 + 0.5 group). Results Differences in the vaccine responses between the 1.0 + 1.0 group and 0.5 + 1.0 group were minor. However, the number of calves with a positive vaccine response to H. somni in the 0.5 + 0.5 group was less than half of that in the 1.0 + 1.0 and 0.5 + 1.0 groups. In logistic regression analysis, although the booster vaccination dose was positively correlated with seropositivity for H. somni, the primary vaccination dose was not correlated with vaccine response. The number of calves with positive vaccine responses to M. haemolytica was low even after booster vaccination regardless of the dose. Conclusions The dose of 0.5 mL can be used for primary vaccinations in newborn Holstein calves, but 1.0 mL may be required for booster vaccinations.

OBJECTIVE To evaluate analgesic efficacy of 3 different preoperative protocols in cows undergoing right flank laparotomy for displaced abomasum. ANIMALS 40 cows diagnosed with displaced abomasum. PROCEDURES The cows were assigned by block randomization to 1 of 3 preoperative protocols: inverted L-block using 50 mL of 2% lidocaine (ILB; n = 13), ILB plus preoperative flunixin meglumine (2 mg/kg, IV; ILB-F; 13), and dorsolumbar epidural anesthesia using 2% xylazine (0.8 mL) and 2% lidocaine (4 mL; EPI; 14). Venous blood samples were collected for CBC, serum biochemistry, and cortisol preoperatively and at 0 (immediately after), 3, 17, and 48 hours postoperatively. RESULTS The mean (95% CI) of the serum cortisol in ILB, ILB-F, and EPI were 108.7 (66.7 to 150.7), 150.7 (116.4 to 185.0), and 139.8 (93.4 to 186.3), respectively. The serum cortisol concentrations decreased over time in all groups (ILB, P = .001; ILB-F and EPI, P < .001). In the ILB group, the cortisol concentration at 17 and 48 hours postoperatively decreased (P = .026 and P = .009, respectively), compared with that preoperatively. In the ILB-F and EPI groups, the preoperative cortisol concentration was the highest and then decreased at 0, 3, 17, and 48 hours postoperatively (ILB-F, 0 hours [P = .001] and 3, 17, and 48 hours [P < .001]; EPI, all [P < .001]). CLINICAL RELEVANCE ILB-F and EPI improved intraoperative and immediate postoperative indicators of pain-related stress when compared to standard ILB. EPI requires less anesthetic, which may be beneficial when in short supply.